Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis

Recruiting now · Phase 1

Conditions studied: Onychomycosis

In brief

3 groups of patients with onychomycosis will be recruited. Group A will receive itraconazole alone. Group B will receive itraconazole + low dose isotretinoin and group C will be treated with itraconazole + excimer light sessions.

Key facts

Study ID

NCT06485505

Run by

Zagazig University

People needed

36

Starts

2024-07-12

Expected to finish

2026-12-01

Last updated by the study team

2026-04-23

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patients with onychomycosis

You may not qualify if…

• pregnant and lactating females patients on statin therapy or photosensitizing drugs patients with liver disease, heart disease and diabetes milletus.

Where it is running

• Zagazig University Hospitals — Zagazig, Zagazig, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.